Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent

<p>Abstract</p> <p>Background</p> <p>Deletion or mutation(s) of the survival motor neuron 1 <it>(SMN1) </it>gene causes spinal muscular atrophy (SMA). The SMN protein is known to play a role in RNA metabolism, neurite outgrowth, and cell survival. Yet, it re...

Full description

Bibliographic Details
Main Authors: Funanage Vicky L, Gómez-Curet Ilsa, Wu Chia-Yen, Scavina Mena, Wang Wenlan
Format: Article
Language:English
Published: BMC 2009-05-01
Series:BMC Cell Biology
Online Access:http://www.biomedcentral.com/1471-2121/10/40
_version_ 1818146818754609152
author Funanage Vicky L
Gómez-Curet Ilsa
Wu Chia-Yen
Scavina Mena
Wang Wenlan
author_facet Funanage Vicky L
Gómez-Curet Ilsa
Wu Chia-Yen
Scavina Mena
Wang Wenlan
author_sort Funanage Vicky L
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Deletion or mutation(s) of the survival motor neuron 1 <it>(SMN1) </it>gene causes spinal muscular atrophy (SMA). The SMN protein is known to play a role in RNA metabolism, neurite outgrowth, and cell survival. Yet, it remains unclear how SMN deficiency causes selective motor neuron death and muscle atrophy seen in SMA. Previously, we have shown that skin fibroblasts from SMA patients are more sensitive to the DNA topoisomerase I inhibitor camptothecin, supporting a role for SMN in cell survival. Here, we examine the potential mechanism of camptothecin sensitivity in SMA fibroblasts.</p> <p>Results</p> <p>Camptothecin treatment reduced the DNA relaxation activity of DNA topoisomerase I in human fibroblasts. In contrast, kinase activity of DNA topoisomerase I was not affected by camptothecin, because levels of phosphorylated SR proteins were not decreased. Upon camptothecin treatment, levels of p53 were markedly increased. To determine if p53 plays a role in the increased sensitivity of SMA fibroblasts to camptothecin, we analyzed the sensitivity of SMA fibroblasts to another DNA topoisomerase I inhibitor, β-lapachone. This compound is known to induce death via a p53-independent pathway in several cancer cell lines. We found that β-lapachone did not induce p53 activation in human fibroblasts. In addition, SMA and control fibroblasts showed essentially identical sensitivity to this compound. By immunofluorescence staining, SMN and p53 co-localized in gems within the nucleus, and this co-localization was overall reduced in SMA fibroblasts. However, depletion of p53 by siRNA did not lessen the camptothecin sensitivity in SMA fibroblasts.</p> <p>Conclusion</p> <p>Even though p53 and SMN are associated, the increased sensitivity of SMA fibroblasts to camptothecin does not occur through a p53-dependent mechanism.</p>
first_indexed 2024-12-11T12:25:24Z
format Article
id doaj.art-5c26f33e739948788b239dff0578dcab
institution Directory Open Access Journal
issn 1471-2121
language English
last_indexed 2024-12-11T12:25:24Z
publishDate 2009-05-01
publisher BMC
record_format Article
series BMC Cell Biology
spelling doaj.art-5c26f33e739948788b239dff0578dcab2022-12-22T01:07:25ZengBMCBMC Cell Biology1471-21212009-05-011014010.1186/1471-2121-10-40Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independentFunanage Vicky LGómez-Curet IlsaWu Chia-YenScavina MenaWang Wenlan<p>Abstract</p> <p>Background</p> <p>Deletion or mutation(s) of the survival motor neuron 1 <it>(SMN1) </it>gene causes spinal muscular atrophy (SMA). The SMN protein is known to play a role in RNA metabolism, neurite outgrowth, and cell survival. Yet, it remains unclear how SMN deficiency causes selective motor neuron death and muscle atrophy seen in SMA. Previously, we have shown that skin fibroblasts from SMA patients are more sensitive to the DNA topoisomerase I inhibitor camptothecin, supporting a role for SMN in cell survival. Here, we examine the potential mechanism of camptothecin sensitivity in SMA fibroblasts.</p> <p>Results</p> <p>Camptothecin treatment reduced the DNA relaxation activity of DNA topoisomerase I in human fibroblasts. In contrast, kinase activity of DNA topoisomerase I was not affected by camptothecin, because levels of phosphorylated SR proteins were not decreased. Upon camptothecin treatment, levels of p53 were markedly increased. To determine if p53 plays a role in the increased sensitivity of SMA fibroblasts to camptothecin, we analyzed the sensitivity of SMA fibroblasts to another DNA topoisomerase I inhibitor, β-lapachone. This compound is known to induce death via a p53-independent pathway in several cancer cell lines. We found that β-lapachone did not induce p53 activation in human fibroblasts. In addition, SMA and control fibroblasts showed essentially identical sensitivity to this compound. By immunofluorescence staining, SMN and p53 co-localized in gems within the nucleus, and this co-localization was overall reduced in SMA fibroblasts. However, depletion of p53 by siRNA did not lessen the camptothecin sensitivity in SMA fibroblasts.</p> <p>Conclusion</p> <p>Even though p53 and SMN are associated, the increased sensitivity of SMA fibroblasts to camptothecin does not occur through a p53-dependent mechanism.</p>http://www.biomedcentral.com/1471-2121/10/40
spellingShingle Funanage Vicky L
Gómez-Curet Ilsa
Wu Chia-Yen
Scavina Mena
Wang Wenlan
Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent
BMC Cell Biology
title Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent
title_full Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent
title_fullStr Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent
title_full_unstemmed Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent
title_short Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent
title_sort increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53 independent
url http://www.biomedcentral.com/1471-2121/10/40
work_keys_str_mv AT funanagevickyl increasedsusceptibilityofspinalmuscularatrophyfibroblaststocamptothecinisp53independent
AT gomezcuretilsa increasedsusceptibilityofspinalmuscularatrophyfibroblaststocamptothecinisp53independent
AT wuchiayen increasedsusceptibilityofspinalmuscularatrophyfibroblaststocamptothecinisp53independent
AT scavinamena increasedsusceptibilityofspinalmuscularatrophyfibroblaststocamptothecinisp53independent
AT wangwenlan increasedsusceptibilityofspinalmuscularatrophyfibroblaststocamptothecinisp53independent